After my first semester of medical school I was treated at @MDAndersonNews for brain cancer. And now, four years later, I’m thrilled to announce I’ll be returning to MD Anderson as a resident physician training to become a Radiation Oncologist! #Match2024
That’s now three separate randomized controlled trials in a row showing benefit from LDRT for osteoarthritis. Does anyone know of any negative RCT vs no treatment control at modern doses (less than 1 Gy per fraction)?
Strong evidence to point to with insurance companies. I’ve seen hundreds of patients benefit and think we need to strongly advocate for our patients to maintain access to this care option.
Thoughtful read on how oncology rewards innovation.
Much of RT progress = precise & efficient tx, improving therapeutic ratio but reducing reimbursement. Systemic advances often =drugs given for yrs.
Current model rewards quantity/duration, but shouldn’t value reflect benefit?
Are you applying to rad onc??
Come see me to chat about MDACC’s rad onc residency program at the UT MD Anderson booth 1733; Hall A-B 4pm-5pm EST on Sunday!
Hope to see y’all there! 🤠
If you’ll be at ASTRO this year come stop by the @UTMDAnderson booth on Sunday, Sep 27th from 4-5 PM (EST) to meet our residents and learn more about our program! #ASTRO26#RadOnc
“How to’ do SBRT in prostate cancer” consensus recommendations is to define minimum requirements, common practices and additional options for prostate SBRT based on scientific evidence, expert opinion and consensus. @RO_GreenJournal@ESTRO_RT
Read it 👉 thegreenjournal.com/article/…
"It’s not just, 'Okay, we’re done treating your cancer. Go back into the world. Good luck.'"
How #survivorship#survonc has improved & what we still need to change in order to provide optimal care for everyone after cancer.
#ACRO2026: cancernetwork.com/view/redef…